It is related to the pathogenesis of Th2-based allergic diseases such as bronchial asthma and AD.[18] Other studies have also proved that serum CCL17 protein levels in patients with bronchial asthma and AD are significantly higher than those in healthy individuals.[19,20]. Here, CCL17 is linked to Alzheimer disease.